Perspectives of the relationship between IL-7 and autoimmune diseases

[1]  T. Olsson,et al.  Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity , 2013, Proceedings of the National Academy of Sciences.

[2]  A. Quintás-Cardama,et al.  Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance , 2013, Clinical Cancer Research.

[3]  A. Adeyemo,et al.  A diverse array of genetic factors contribute to the pathogenesis of Systemic Lupus Erythematosus , 2013, Orphanet Journal of Rare Diseases.

[4]  Geneviève Depresseux,et al.  Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus , 2012, Annals of the rheumatic diseases.

[5]  P. Emery,et al.  Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels , 2012, Annals of the rheumatic diseases.

[6]  V. Kapoor,et al.  High levels of IL-7 cause dysregulation of thymocyte development. , 2012, International immunology.

[7]  M. Wahren-Herlenius,et al.  IL‐17: A new actor in IFN‐driven systemic autoimmune diseases , 2012, European journal of immunology.

[8]  B. Oostra,et al.  Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients , 2012, Genes and Immunity.

[9]  C. Harrison.  Autoimmune disease: Targeting IL-7 reverses type 1 diabetes , 2012, Nature Reviews Drug Discovery.

[10]  Clement Kwamina Insaidoo Appah,et al.  Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function , 2012, Proceedings of the National Academy of Sciences.

[11]  J. Bluestone,et al.  IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells , 2012, Proceedings of the National Academy of Sciences.

[12]  A. Rolink,et al.  The key role of IL-7 in lymphopoiesis. , 2012, Seminars in immunology.

[13]  J. Bijlsma,et al.  IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Rα. , 2012, Rheumatology.

[14]  Jung-Hyun Park,et al.  Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. , 2012, Seminars in immunology.

[15]  F. Carrette,et al.  IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. , 2012, Seminars in immunology.

[16]  C. Mackall,et al.  IL-7 in human health and disease. , 2012, Seminars in immunology.

[17]  C. Paige,et al.  The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation. , 2012, Seminars in immunology.

[18]  F. Lafeber,et al.  Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. , 2012, Current pharmaceutical design.

[19]  A. Kijlstra,et al.  Increased IL-7 expression in Vogt-Koyanagi-Harada disease. , 2012, Investigative ophthalmology & visual science.

[20]  K. Tenbrock,et al.  Inflammatory Cytokines in Systemic Lupus Erythematosus , 2011, Journal of biomedicine & biotechnology.

[21]  M. Volin,et al.  Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[22]  C. Polman,et al.  IL-7 Promotes TH1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis , 2011, Science Translational Medicine.

[23]  C. Walline,et al.  IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis , 2011, Genes and Immunity.

[24]  David M Maahs,et al.  Epidemiology of type 1 diabetes. , 2010, Endocrinology and metabolism clinics of North America.

[25]  M. Busslinger,et al.  STAT5 in B cell development and leukemia. , 2010, Current opinion in immunology.

[26]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[27]  J. Thèze,et al.  Interleukin-7 Compartmentalizes Its Receptor Signaling Complex to Initiate CD4 T Lymphocyte Response* , 2010, The Journal of Biological Chemistry.

[28]  Jingwu Z. Zhang,et al.  Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease , 2010, Nature Medicine.

[29]  Glinda S Cooper,et al.  Understanding the epidemiology and progression of systemic lupus erythematosus. , 2010, Seminars in arthritis and rheumatism.

[30]  G. Firestein,et al.  Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.

[31]  T. Makino,et al.  Decreased serum IL-7 levels in patients with systemic sclerosis. , 2009, Clinical and experimental rheumatology.

[32]  A. Sharabi,et al.  A tolerogenic peptide down‐regulates mature B cells in bone marrow of lupus‐afflicted mice by inhibition of interleukin‐7, leading to apoptosis , 2009, Immunology.

[33]  T. Mcclanahan,et al.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.

[34]  S. Walsh,et al.  Structural and biophysical studies of the human IL-7/IL-7Ralpha complex. , 2009, Structure.

[35]  J. Sprent,et al.  IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia1 , 2008, The Journal of Immunology.

[36]  F. Ponchel,et al.  Interleukin-7 in rheumatoid arthritis. , 2008, Rheumatology.

[37]  D. Ye,et al.  Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus , 2008, Nature Clinical Practice Rheumatology.

[38]  D. Lauffenburger,et al.  Interleukin-7 Receptor Signaling Network: An Integrated Systems Perspective , 2008, Cellular and Molecular Immunology.

[39]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[40]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[41]  I. Alexander,et al.  Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors. , 2007, Blood.

[42]  J. Bijlsma,et al.  Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[43]  R. Mazzucchelli,et al.  Interleukin-7 receptor expression: intelligent design , 2007, Nature Reviews Immunology.

[44]  Q. Jiang,et al.  Role of the Intracellular Domain of IL-7 Receptor in T Cell Development1 , 2007, The Journal of Immunology.

[45]  T. Hirano,et al.  Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7–dependent homeostatic proliferation of CD4+ T cells , 2006, The Journal of experimental medicine.

[46]  L. Presta,et al.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. , 2006, The Journal of clinical investigation.

[47]  G. Freeman,et al.  Tissue expression of PD-L1 mediates peripheral T cell tolerance , 2006, The Journal of experimental medicine.

[48]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[49]  C. Paige,et al.  IL-7: a key regulator of B lymphopoiesis. , 2006, Seminars in immunology.

[50]  Stephen L. Hauser,et al.  Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis , 2005, Journal of Neuroimmunology.

[51]  Q. Jiang,et al.  Cell biology of IL-7, a key lymphotrophin. , 2005, Cytokine & growth factor reviews.

[52]  J. Bijlsma,et al.  Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. , 2005, Arthritis and rheumatism.

[53]  S. Frøland,et al.  Abnormal interleukin-7 function in common variable immunodeficiency. , 2005, Blood.

[54]  S. Kingsmore,et al.  Protein Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease Demonstrates Elevated Serum PLGF, IL-7, TGF-β1, and IL-12p40 Levels in Crohn's Disease and Ulcerative Colitis Patients in Remission versus Active Disease , 2005, The American Journal of Gastroenterology.

[55]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[56]  L. Ivashkiv,et al.  Signaling by STATs , 2004, Arthritis research & therapy.

[57]  B. Torok-Storb,et al.  Expression and Function of IL-7 Receptors in Marrow Stromal Cells , 2004, Leukemia & lymphoma.

[58]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.

[59]  J. Bijlsma,et al.  Interleukin 7 stimulates tumour necrosis factor α and Th1 cytokine production in joints of patients with rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[60]  T. Fry,et al.  Interleukin-7: from bench to clinic. , 2002, Blood.

[61]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[62]  K. Muegge,et al.  Interleukin (IL)-7 Induces Rapid Activation of Pyk2, Which Is Bound to Janus Kinase 1 and IL-7Rα* , 2000, The Journal of Biological Chemistry.

[63]  H. Makino,et al.  Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[64]  I. Weissman,et al.  Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice , 1997, Cell.

[65]  Z. Ota,et al.  Stimulation by interleukin-7 of mononuclear cells in peripheral blood, synovial fluid and synovial tissue from patients with rheumatoid arthritis. , 1993, Acta medica Okayama.

[66]  D. McFarlin,et al.  Multiple sclerosis (second of two parts). , 1982, The New England journal of medicine.

[67]  D. McFarlin,et al.  Multiple sclerosis (first of two parts). , 1982, The New England journal of medicine.

[68]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[69]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.